Tofacitinib for juvenile idiopathic arthritis - Authors' reply

Lancet. 2022 May 14;399(10338):1866. doi: 10.1016/S0140-6736(22)00837-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arthritis, Juvenile* / drug therapy
  • Humans
  • Piperidines / therapeutic use
  • Pyrimidines / therapeutic use

Substances

  • Piperidines
  • Pyrimidines
  • tofacitinib